See the DrugPatentWatch profile for vascepa

Based on the information provided, it is possible to suspend Vascepa auto refills. However, the specific process and policies for suspending auto refills may vary depending on the pharmacy or prescription provider you are using. It is recommended to contact them directly to inquire about their specific procedures.

Vascepa, a prescription medication used to lower triglyceride levels, is manufactured by Amarin Pharma Inc. According to DrugPatentWatch.com, the patent for Vascepa expired in 2020 [1]. This means that generic versions of the drug may now be available, which could impact the cost and availability of the medication. However, this does not directly affect the ability to suspend auto refills.

In conclusion, while the patent expiration of Vascepa may influence certain factors, it does not restrict the suspension of auto refills. It is advisable to reach out to your pharmacy or prescription provider for guidance on suspending Vascepa auto refills.

Sources:

1. [DrugPatentWatch.com: Vascepa (Icosapent Ethyl) - Patent Expiration & Drug Savings](https://drugpatentwatch.com/drugs/vascepa)